Abingworth LLP

Insider Reports History

Entity
Company
Location
38 Jermyn Street, London, United Kingdom
Signature
/s/ John Heard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Abingworth LLP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SOLENO THERAPEUTICS INC 10%+ Owner Common Stock 18M $658M $36.49 Mar 29, 2022 Indirect
Sierra Oncology, Inc. 10%+ Owner Common Stock, $0.001 par value 1.31M $72.3M $55.00 Jan 31, 2022 Indirect
Vera Therapeutics, Inc. 10%+ Owner Class A Common Stock 2.96M $53.3M $18.00 May 18, 2021 Indirect
SOLENO THERAPEUTICS INC 10%+ Owner Warrant (right to buy) 7.72M Mar 29, 2022 Indirect
Jasper Therapeutics, Inc. 10%+ Owner Stock Option (right to buy) 78K Mar 21, 2022 Indirect
eFFECTOR Therapeutics, Inc. 10%+ Owner Stock Option (right to buy) 40K Oct 6, 2021 Indirect
SOLENO THERAPEUTICS INC 10%+ Owner Stock Option (right to buy) 31.9K Jun 1, 2021 Indirect
Vera Therapeutics, Inc. 10%+ Owner Stock Option (right to buy) 9.93K May 13, 2021 Indirect
Sierra Oncology, Inc. 10%+ Owner Series B Warrants (right to buy) 0 Jan 28, 2022 Indirect

Insider Reports Filed by Abingworth LLP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JSPR Jasper Therapeutics, Inc. Mar 21, 2022 1 $0 4 Mar 23, 2022 10%+ Owner
SRRA Sierra Oncology, Inc. Jan 28, 2022 3 $7.84M 4 Feb 1, 2022 10%+ Owner
SRRA Sierra Oncology, Inc. Nov 5, 2021 0 $0 3 Nov 5, 2021 10%+ Owner
EFTR eFFECTOR Therapeutics, Inc. Oct 6, 2021 1 $0 4 Dec 17, 2021 10%+ Owner
JSPR Jasper Therapeutics, Inc. Sep 24, 2021 0 $0 3 Oct 1, 2021 10%+ Owner
EFTR eFFECTOR Therapeutics, Inc. Aug 25, 2021 0 $0 3 Aug 27, 2021 10%+ Owner
VERA Vera Therapeutics, Inc. May 13, 2021 3 $8.5M 4 May 18, 2021 10%+ Owner
VERA Vera Therapeutics, Inc. May 13, 2021 0 $0 3 May 13, 2021 10%+ Owner
SLNO SOLENO THERAPEUTICS INC Dec 21, 2018 7 $0 4 Mar 31, 2022 10%+ Owner